Tevogen Bio evaluates CRO acquisition worth over $20 million annually

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Tevogen Bio evaluates CRO acquisition worth over $20 million annually
(NASDAQ: TVGN) Delayed: 9.82 +0.36 (3.81%)
Previous Close $9.46    52 Week High $ 
Open $8.97    52 Week Low $ 
Day High $10.10    P/E N/A 
Day Low $8.97    EPS $ 
Volume 10,972